ARTICLES BY THIS AUTHOR
- 7/23/2023
POP QUIZ: Primary immunization with bivalent COVID-19 vaccines
Did you keep up with the latest NACI guidance? - 7/20/2023
Experts advocate prescribing psychostimulants for stimulant use disorder
They suggest that this practice would reduce reliance on illegal stimulants during the ongoing drug poisoning crisis. - 7/17/2023
Pfizer bivalent COVID-19 vaccine now approved for primary immunization
Comirnaty Original and Omicron BA.4/BA.5 vaccine is now indicated for primary immunization, as well as for bivalent booster, in individuals five years of age or older. - 7/12/2023
Serotonergic antidepressants increase bleeding risk in orthopedic surgery
Patients taking serotonergic antidepressants in the perioperative period have higher transfusion requirements and a longer hospital stay. - 7/11/2023
Drug news—July 2023
A review of new launches, new indications, new dosage forms and Health Canada advisories. - 7/10/2023
Health Canada grants conditional approval for Ondexxya to reverse FXa inhibitor anticoagulant effects
Andexanet alfa will be used intravenously to rapidly reverse life-threatening or uncontrolled bleeding due to rivaroxaban or apixaban. - 7/6/2023
U.S. community pharmacies recognized for contributions to public health during pandemic
However, some still firmly oppose any effort to increase pharmacists’ scope of practice, including those related to public health activities. - 7/4/2023
POP QUIZ: Zoryve cream for plaque psoriasis
Roflumilast 0.3% cream (Zoryve) recently became available in Canada for the topical treatment of plaque psoriasis. - 7/3/2023
Three tick-borne diseases added to the reportable disease list in Ontario
Anaplasmosis, babesiosis and Powassan virus are now classified as 'Diseases of Public Health Significance' and have been added to the reportable disease list in Ontario.